Jefferies Group buys $86,664,930 stake in Baxter International Inc (BAX)

Baxter International Inc (BAX) : Jefferies Group scooped up 1,340,670 additional shares in Baxter International Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 12, 2016. The investment management firm now holds a total of 1,783,596 shares of Baxter International Inc which is valued at $86,664,930.Baxter International Inc makes up approximately 2.97% of Jefferies Group’s portfolio.

Other Hedge Funds, Including , Ft Options sold out all of its stake in BAX during the most recent quarter. The investment firm sold 100,000 shares of BAX which is valued $4,859,000.Omers Administration Corp reduced its stake in BAX by selling 879 shares or 1.01% in the most recent quarter. The Hedge Fund company now holds 86,221 shares of BAX which is valued at $4,189,478. Baxter International Inc makes up approx 0.09% of Omers Administration Corp’s portfolio.Ubs Asset Management Americas Inc boosted its stake in BAX in the latest quarter, The investment management firm added 316,399 additional shares and now holds a total of 2,042,142 shares of Baxter International Inc which is valued at $100,126,222. Baxter International Inc makes up approx 0.11% of Ubs Asset Management Americas Inc’s portfolio.

Baxter International Inc opened for trading at $47.29 and hit $47.54 on the upside on Monday, eventually ending the session at $47.41, with a gain of 0.49% or 0.23 points. The heightened volatility saw the trading volume jump to 34,94,534 shares. Company has a market cap of $25,786 M.

On the company’s financial health, Baxter International Inc reported $0.46 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Jul 26, 2016. Analyst had a consensus of $0.40. The company had revenue of $2585.00 million for the quarter, compared to analysts expectations of $2516.16 million. The company’s revenue was up 4.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.00 EPS.

Investors should note that on Jul 19, 2016, Baxter International Inc announced a cash dividend of $0.1300. The company’s management has announced Aug 31, 2016 as the ex-dividend date and fixed the record date on Sep 2, 2016. The payable date has been fixed on Oct 3, 2016.

Many Wall Street Analysts have commented on Baxter International Inc. Company shares were Reiterated by RBC Capital Mkts on Jul 27, 2016 to “Sector Perform”, Firm has raised the Price Target to $ 50 from a previous price target of $47 .Baxter International Inc was Resumed by JP Morgan to “Neutral” on Jun 6, 2016.

Baxter International Inc. (Baxter) is a diversified healthcare company. The Company operates in two segments: BioScience segment which include three commercial franchises: Hemophilia BioTherapeutics and BioSurgery and Medical Products segment which include four commercial franchises: Fluid Systems Renal Specialty Pharmaceuticals and BioPharma Solutions. Its BioScience processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies alpha-1 antitrypsin deficiency burns and shock and other chronic and acute blood-related conditions and biosurgery products. Its Medical Products manufactures intravenous (IV) solutions and administration sets premixed drugs and drug-reconstitution systems pre-filled vials and syringes for injectable drugs IV nutrition products infusion pumps and inhalation anesthetics. Its products are used in hospitals kidney dialysis centers and nursing homes among others.

Leave a Reply

Baxter International Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Baxter International Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.